Company Research Report: Carbometrics Ltd.

Company Overview

• Name: Carbometrics Ltd.

• Mission: Molecular recognition inspired by nature, designed by scientists.

• Founded: 2018 following the acquisition of Ziylo Ltd by Novo Nordisk.

• Founders: Dr. Andy Chapman, Dr. Harry Destecroix, Keith MacDonald, Chris Jones, and Prof. Anthony Davis.

• Headquarters: Science Creates St Philips, St Philips Central, Albert Road, Bristol BS2 0XJ, United Kingdom.

• Number of Employees: No specific number available.

• Revenue: No information is available.

• Known For: Design and synthesis of highly selective and robust synthetic Glucose Binding Molecules (GBMs) for non-therapeutic applications such as Continuous Glucose Monitoring (CGM).

Key People

• Dr. Andy Chapman - CEO & Co-Founder

• Dr. Harry Destecroix - Director & Co-Founder

• Keith MacDonald - Chairman & Co-Founder

• Chris Jones - Non-Executive Director

• Prof. Anthony Davis - Scientific Advisor & Co-Founder

Products

Glucose Binding Molecules (GBMs)

• Description: Carbometrics' core technology focuses on GBMs which are the world's most selective synthetic molecules designed to bind glucose.

• Key Features:

• Versatile Signal Coupling: Utilizes both optical and electrochemical signals for glucose sensing assays.

• High Selectivity: Minimizes interferences in glucose detection.

• Stability: Thermally, hydrolytically, and oxidatively stable; can withstand extreme conditions such as high temperature and extreme pH.

• Scalability: Produced through streamlined and scalable synthesis.

• Potential Applications: Long-term implantables, due to their robustness and stability.

Recent Developments

New Products and Features

• Glucose Responsive Insulin: Developed in collaboration with Novo Nordisk to improve diabetes management by developing an insulin that responds to blood glucose levels.

• Optical Glucose Sensor Collaboration: Working with PyroScience to develop a world's first optical glucose sensor for bioprocessing and cell culture applications.

Partnerships and Collaborations

• Novo Nordisk: Partnership focused on developing glucose-sensitive artificial insulin.

• PyroScience GmbH: Collaboration to create a reliable optical glucose sensor.

• Argonaute RNA: Synthetic and analytical chemistry services to support RNAi-based therapeutics development.

• Rosa Biotech: Innovate UK funded project to create electrochemical probes for biosensing and diagnostics.

• Epinal: Analytical services to validate narcotic biosensors for roadside detection.

Other Updates

• Memberships and Recognitions:

• Member of the BioIndustry Association (BIA) since July 2024.

• Co-founder awarded 2023 Chemistry World Entrepreneur of the Year.

• Awards and Grants:

• Success in obtaining a UKRI R&D grant in September 2023.

• Previous funding round in May 2021 totaling £2.1m from investors.

No additional commentary provided, focusing strictly on the data available.